In this file
The consultation itself is an important cancellation boundary. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
NewSelf markets compounded semaglutide and tirzepatide with stated added ingredients and an online medical visit. Its product cards distinguish ordinary monthly figures from lower promotional equivalents. Before comparing the plans, identify the proposed preparation and whether the offer involves a longer payment commitment.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
The homepage displays semaglutide at $134.99 monthly and tirzepatide at $224.99 monthly, together with lower as-low-as figures of $99.97 and $144.49. Ask what purchase term and eligibility conditions produce those lower amounts. An introductory figure should not be treated as an ongoing personal quote.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
The published policy says a written cancellation request before the doctor visit may qualify for a refund less a $99 administrative fee. It says cancellation and refunds are unavailable after the consultation because an approved prescription is transmitted for fulfillment. Ending a subscription in the dashboard addresses future renewals, not necessarily the current order.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
NewSelf names added ingredients in its compounded products. Those combinations should be evaluated as the actual preparations being prescribed, rather than borrowing an approved brand’s trial results. Ask the clinician which ingredients are necessary for your treatment and which pharmacy supplies them.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
NewSelf’s published contact number is (855) 606-5232. The documented email route is support@newself.com.
Written cancellation requests should also follow the published policy and its consultation cutoff.
Start from the official NewSelf website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
What is the complete commitment behind the lower advertised figure, and which charges become non-refundable when the medical visit occurs?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Compare a different arrangement
The NewSelf alternatives guide compares care and payment structures relevant to this file. CoreAge Rx’s first place in that list is a disclosed commercial placement, not an independent clinical ranking.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Returns and Refund ↗Provider-published information · Checked September 22, 2026
- NewSelf Weight Loss Protocol ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026